Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene in adult paucisymptomatic COVID-19 patients
2020-003936-25Phase 2Terminated
- Sponsor
- Dompé
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of raloxifene in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Dompé. Primary endpoint: Virologic outcome at day 7. Started Nov 2020; status: terminated.
02
Drugs
raloxifene
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-003936-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003936-25.